Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy

Pulmonary Pharmacology and Therapeutics

Volumn 23, Issue 3, 2010, Pages 200-207

  Blasi, Francesco ^a   Bonardi, Daniela ^a   Aliberti, Stefano ^a   Tarsia, Paolo ^a   Confalonieri, Marco ^b   Amir, Omar ^c   Carone, Mauro ^d   Di Marco, Fabiano ^a   Centanni, Stefano ^a   Guffanti, Enrico ^e  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d IRCCS   (Italy)

^e INRCA   (Italy)

Author keywords

Acute exacerbation of chronic bronchitis; COPD; Macrolide; Tracheostomy

Indexed keywords

AZITHROMYCIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH PAIN; TRACHEOSTOMY;

AGED; AGED, 80 AND OVER; AZITHROMYCIN; BODY MASS INDEX; FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MACROLIDES; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SMOKING; TRACHEOSTOMY;

EID: 77950337693     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.12.002     Document Type: Article

References (26)

1. Niederman M.S., Ferranti R.D., Zeigler A., Merrill W.W., and Reynolds H.Y. Respiratory infections complicating long-term tracheostomy: the implications of persistent Gram-negative tracheobronchial colonization. Chest 85 (1984) 39-44
2. Harlid R., Andersson G., Frostell C.G., Jorbeck H.J.A., and Ortqvist A.B. Respiratory tract colonization and infection in patients with chronic tracheostomy. A one-year study in patients living at home. Am J Respir Crit Care Med 154 (1996) 124-129
3. Lusuardi M., Capelli A., Cerutti C.G., Gnemmi I., Zaccaria S., and Donner C.F. Influence of clinical history on airways bacterial colonization in subjects with chronic tracheostomy. Respir Med 94 (2000) 436-440
4. Stockley R.A. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection. Thorax 53 (1998) 58-62
5. Hill A.T., Campbell E.J., Hill S.L., Bayley D.L., and Stockley R.A. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 109 (2000) 288-295
6. Wilkinson T.M., Patel I.S., Wilks M., Donaldson G.C., and Wedzicha J.A. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167 (2003) 1090-1095
7. Patel I.S., Seemungal T.A., Wilks M., Lloyd-Owen S.J., Donaldson G.C., and Wedzicha J.A. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57 (2002) 759-764
8. Seemungal T.A., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., and Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1418-1422
9. Chapman K.R., Mannino D.M., Soriano J.B., Vermeire P.A., Buist A.S., Thun M.J., et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 27 1 (2006) 188-207
10. Crosbie P.A., and Woodhead M.A. Long-term macrolide therapy in chronic inflammatory airway diseases. Eur Respir J 33 1 (2009) 171-181
11. Verleden G.M., Vanaudenaerde B.M., Dupont L.J., and Van Raemdonck D.E. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 174 5 (2006) 566-570
12. Tsai W.C., Rodriguez M.L., Young K.S., Deng J.C., Thannickal V.J., Tateda K., et al. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 170 (2004) 1331-1339
13. Johnston S.L., Blasi F., Black P.N., Martin R.J., Farrell D.J., and Nieman R.B. TELICAST Investigators. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 354 15 (2006) 1589-1600
14. Kudoh S., Azuma A., Yamamoto M., Izumi T., and Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157 (1998) 1829-1832
15. Tsang K.W., Ho P.I., Chan K.N., Ip M.S., Lam W.K., Ho C.S., et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J 13 2 (1999) 361-364
16. Equi A., Balfour-Lynn I.M., Bush A., and Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 360 9338 (2002) 978-984
17. Wolter J., Seeney S., Bell S., Bowler S., Masel P., and McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomized trial. Thorax 57 (2002) 212-216
18. Seemungal T.A., Wilkinson T.M., Hurst J.R., Perera W.R., Sapsford R.J., and Wedzicha J.A. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 178 11 (2008) 1139-1147
19. Vidotto G., Carone M., Jones P.W., Salini S., Bertolotti G., and on behalf of the Quess Group. Maugeri Respiratory Failure questionnaire reduced form: method for improving the questionnaire using the Rasch model. Disabil Rehabil 29 13 (2007) 991-998
20. Isenberg H.D., Baron E.J., and Damato R.F. Recommendations for the isolation of bacteria from clinical specimens. In: Balows A., Hausler Jr. W.J., Hermann K.L., et al. (Eds). Manual of clinical microbiology (1991), American Society for Microbiology, Washington 216-237
21. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility. 4th ed. NCCLS Document M02-A4 (1990), NCCLS, Villanova
22. Gerhardt S.G., McDyer J.F., Girgis R.E., Conte J.V., Yang S.C., and Orens J.B. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 168 1 (2003) 121-125
23. Basyigit I., Yildiz F., Ozkara S.K., Yildirim E., Boyaci H., and Ilgazli A. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data. Ann Pharmacother 38 (2004) 1400-1405
24. Kobayashi H. Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. Am J Med 99 (1995) 26S-30S
25. Yasuda H., Ajiki Y., Koga T., Kawada H., and Yokota T. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 37 (1993) 1749-1755
26. Imamura Y., Higashiyama Y., Tomono K., Izumikawa K., Yanagihara K., Ohno H., et al. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob Agents Chemother 49 4 (2005) 1377-1380